Chapters
| Status | Drug name | NICE TAs | Comments |
|---|---|---|---|
 | Anti-D (Rh0) immunoglobulin | ||
| Casirivimab plus imdevimab (Ronapreve®) | ||
| Gammanorm | ||
| Hepatitis B | ||
| Hizentra | ||
| Normal Immunoglobulin Infusion FLEBOGAMMA | ||
| Normal Immunoglobulin Infusion GAMMAPLEX | ||
| Normal Immunoglobulin Infusion OCTAGAM | ||
| Normal Immunoglobulin Infusion VIGAM | ||
 | Pneumococcal polysaccharide vaccine (Pneumovax®II) | Protects from each of 23 types of pneumococcus | |
| Rabies immunoglobulin | ||
| Sotrovimab (Xevudy®) | ||
| Subcuvia | ||
| Subgam | ||
| Tetanus immunoglobulin 250units injection | ||
| Varicella-zoster immunoglobulin |
Drug status key
Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.
Grey
Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.
Red
Initiation and maintenance of prescribing by specialists only.
Amber
Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.
Green
Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.
Blue
Under review at University Hospitals Birmingham NHS Foundation Trust.
